What is the most recent earnings date for STSA stock?
Satsuma Pharmaceuticals Inc (STSA) last reported earnings on 5/11/2023.
NASDAQ:STSA • US80405P1075
Past quarterly earnings results for Satsuma Pharmaceuticals Inc (STSA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2023 | -0.31 | -0.30 | -3.02% | 36.73% | - | - | ||
| Q4 2022 | -0.70 | -0.37 | -89.37% | -42.86% | - | - | ||
| Q3 2022 | -0.48 | -0.55 | 13.37% | -14.29% | - | - | ||
| Q2 2022 | -0.52 | -0.50 | -4.04% | -36.84% | - | - | ||
| Q1 2022 | -0.49 | -0.50 | 2.62% | -2.08% | - | - | ||
| Q4 2021 | -0.49 | -0.49 | 0.95% | 31.94% | - | - | ||
| Q3 2021 | -0.42 | -0.52 | 19.26% | 39.13% | - | - | ||
| Q2 2021 | -0.38 | -0.42 | 9.87% | 41.54% | - | - | ||
| Q1 2021 | -0.48 | -0.43 | -12.94% | 29.41% | - | - | ||
| Q4 2020 | -0.72 | -0.54 | -33.50% | - | - | - | ||
| Q3 2020 | -0.69 | -0.71 | 2.61% | - | - | - | ||
| Q2 2020 | -0.65 | -0.73 | 10.66% | - | - | - | ||
| Q1 2020 | -0.68 | -0.68 | 0.50% | - | - | - |
Notes
Satsuma Pharmaceuticals Inc (STSA) last reported earnings on 5/11/2023.
Satsuma Pharmaceuticals Inc (STSA) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, Satsuma Pharmaceuticals Inc (STSA) has beaten EPS estimates in 1 out of 4 releases.